MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival. | Gynecol Oncol;126(3): 460-5, 2012 Sep. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

MGST1 expression in serous ovarian carcinoma differs at various anatomic sites, but is unrelated to chemoresistance or survival.

Hetland, Thea Eline; Nymoen, Dag Andre; Emilsen, Elisabeth; Kærn, Janne; Tropé, Claes G; Flørenes, Vivi Ann; Davidson, Ben.

Affiliation

Hetland TE; Departement of Gynecologic Oncology, Oslo University Hospital, Norwegian Radium Hospital, N-0424 Oslo, Norway.

Gynecol Oncol ; 126(3): 460-5, 2012 Sep.

Article in En | MEDLINE | ID: mdl-22652154

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Ascitic Fluid / Carcinoma / Pleural Effusion, Malignant / Glutathione Transferase Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2012 Document type: Article Affiliation country: Country of publication:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Ascitic Fluid / Carcinoma / Pleural Effusion, Malignant / Glutathione Transferase Limits: Female / Humans Language: En Journal: Gynecol Oncol Year: 2012 Document type: Article Affiliation country: Country of publication: